PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, AC. Simões campus, Lourival Melo Mota Avenue, Maceió, 57072-970, Brazil.\', \'Institute of Chemistry and Biotechnology, Federal University of Alagoas, AC. Simões campus, Lourival Melo Mota Avenue, Maceió, 57072-970, Brazil.\', \'Laboratory of Neuroscience and Pharmacological Assays (LANEF), Department of Physiology, Federal University of Sergipe, Av. Marechal Rondom, s/n, São Cristóvão, Sergipe, 49.100-000, Brazil. luahei@yahoo.com.br.\', \'Investigative Pathology Laboratory, Federal University of Sergipe, Aracaju, Sergipe, Brazil.\', \'Laboratory of Neuroscience and Pharmacological Assays (LANEF), Department of Physiology, Federal University of Sergipe, Av. Marechal Rondom, s/n, São Cristóvão, Sergipe, 49.100-000, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00210-022-02206-6
?:doi
?:hasPublicationType
?:journal
  • Naunyn-Schmiedeberg\'s archives of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 35089406
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.836
?:rankingScore_hIndex
  • 84
?:title
  • Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35089406>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35089406>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all